Thomas Cahill's most recent trade in Prime Medicine Inc was a trade of 45,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Aug. 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Prime Medicine Inc | Thomas Cahill | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Aug 2025 | 45,000 | 0 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Thomas Cahill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2025 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Thomas Cahill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2025 | 39,062 | 39,062 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Thomas Cahill | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Aug 2025 | 39,062 | 0 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Thomas Cahill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 55,000 | 55,000 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Thomas Cahill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Thomas Cahill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 39,062 | 39,062 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Thomas Cahill | Director | 24 Oct 2022 | 9,999,999 | 0 | - | - | Series A Convertible Preferred Stock | ||
| Prime Medicine Inc | Thomas Cahill | Director | 24 Oct 2022 | 5,250,781 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Prime Medicine Inc | Thomas Cahill | Director | 24 Oct 2022 | 4,905,679 | 4,905,679 | - | - | Common Stock | ||
| Prime Medicine Inc | Thomas Cahill | Director | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 24 Oct 2022 | 400,000 | 5,305,679 | - | 17 | 6,800,000 | Common Stock |